Both in Biotechnology
Metagenomi Therapeutics vs Tevogen
Over the past year MGX returned −50.9% and TVGN returned −82.9%; their daily moves had a correlation of 0.15.
MGX −50.9% TVGN −82.9%Growth of $1, one year, split-adjusted
| Metric | MGX | TVGN |
|---|---|---|
| Price | $1.13 | $6.75 |
| Market cap | $42.7M | $44.0M |
| Today | −0.88% | −0.15% |
| 1 month | −5.0% | −2.0% |
| 6 months | −10.7% | +57.3% |
| Year to date | −30.2% | −59.2% |
| 1 year | −50.7% | — |
| Revenue growth (YoY) | −103.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 3.1× | — |
| Net cash | $120.7M | -$7.0M |
| Dividend yield | — | — |
| Volatility (60d) | 27.2% | 80.4% |
| Short % of float | 6.4% | 4.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).